Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Murphy

Showing results (501-510 of 643) with videos related to

Pageof 65
Sort By:
Pharmacology, Biochemistry, and Behavior|March 1, 1982
Lifetime monoamine oxidase inhibition and sleepW B Mendelson, R M Cohen, I C Campbell, et al.
Psychopharmacology|January 1, 1988
Intravenous nicotine in Alzheimer's disease: a pilot studyP A Newhouse, T Sunderland, P N Tariot, et al.
European Journal of Pharmacology|August 14, 1991
Differential effects of long-term lithium and carbamazepine administration on Gs alpha and Gi alpha protein in rat brainK P Lesch, C S Aulakh, T J Tolliver, et al.
The American Journal of Psychiatry|March 1, 1993
CSF somatostatin in obsessive-compulsive disorderM Altemus, T Pigott, F L'Heureux, et al.
Archives of General Psychiatry|January 1, 1970
Sodium balance and distribution in lithium carbonate therapyL Baer, J Durell, W E Bunney, et al.
The Journal of Physiology|January 1, 1977
Quantitative evaluation of the loss of human platelet dense bodies following stimulation by thrombin or A23187J L Costa, T C Detwiler, R D Feinman, et al.
Psychopharmacology|January 1, 1987
Cognitive effects of L-deprenyl in Alzheimer's diseaseP N Tariot, T Sunderland, H Weingartner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 29, 2000
Adrenergic and noradrenergic plasma levels in Lesch-Nyhan diseaseM Ernst, A J Zametkin, D Pascualvaca, et al.
Psychopharmacology|January 15, 1999
Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patientsB D Greenberg, J Benjamin, J D Martin, et al.
Biological Psychiatry|May 15, 1995
Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controlsD Garcia-Borreguero, F M Jacobsen, D L Murphy, et al.
Pageof 65

Showing results (501-510 of 643) with videos related to

Sort By:
Pageof 65
Pharmacology, Biochemistry, and Behavior|March 1, 1982
Lifetime monoamine oxidase inhibition and sleepW B Mendelson, R M Cohen, I C Campbell, et al.
Psychopharmacology|January 1, 1988
Intravenous nicotine in Alzheimer's disease: a pilot studyP A Newhouse, T Sunderland, P N Tariot, et al.
European Journal of Pharmacology|August 14, 1991
Differential effects of long-term lithium and carbamazepine administration on Gs alpha and Gi alpha protein in rat brainK P Lesch, C S Aulakh, T J Tolliver, et al.
The American Journal of Psychiatry|March 1, 1993
CSF somatostatin in obsessive-compulsive disorderM Altemus, T Pigott, F L'Heureux, et al.
Archives of General Psychiatry|January 1, 1970
Sodium balance and distribution in lithium carbonate therapyL Baer, J Durell, W E Bunney, et al.
The Journal of Physiology|January 1, 1977
Quantitative evaluation of the loss of human platelet dense bodies following stimulation by thrombin or A23187J L Costa, T C Detwiler, R D Feinman, et al.
Psychopharmacology|January 1, 1987
Cognitive effects of L-deprenyl in Alzheimer's diseaseP N Tariot, T Sunderland, H Weingartner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 29, 2000
Adrenergic and noradrenergic plasma levels in Lesch-Nyhan diseaseM Ernst, A J Zametkin, D Pascualvaca, et al.
Psychopharmacology|January 15, 1999
Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patientsB D Greenberg, J Benjamin, J D Martin, et al.
Biological Psychiatry|May 15, 1995
Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controlsD Garcia-Borreguero, F M Jacobsen, D L Murphy, et al.
Pageof 65